Tpbpa inhibitors are a class of chemical compounds designed to specifically target the Tpbpa protein, a critical component of certain biochemical pathways. These inhibitors primarily function by binding to the active site of the Tpbpa protein, effectively preventing the natural substrate or ligand from interacting with the protein. By blocking this interaction, the inhibitors halt the protein's normal activity, leading to a disruption of the associated biochemical process. In some cases, Tpbpa inhibitors may also bind to allosteric sites, which are regions on the protein away from the active site. Binding at these sites can induce conformational changes that reduce or eliminate the functional capabilities of the protein. The effectiveness of Tpbpa inhibitors relies on their ability to form stable, non-covalent interactions with the protein, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and electrostatic interactions, which collectively enhance the stability and specificity of the inhibitor-protein complex.
The chemical structure of Tpbpa inhibitors varies widely, allowing for a range of molecular designs tailored to the unique binding sites of the Tpbpa protein. These inhibitors often feature key structural elements such as aromatic rings, heterocycles, and functional groups like hydroxyl, carboxyl, or amine groups, which facilitate specific interactions with the protein's binding pockets. The incorporation of these functional groups enables the formation of hydrogen bonds with polar amino acid residues and hydrophobic contacts with non-polar regions of the protein. Additionally, the physicochemical properties of Tpbpa inhibitors, such as molecular weight, solubility, lipophilicity, and polarity, are optimized to ensure proper binding and stability in various environments. This balance of hydrophilic and hydrophobic regions allows the inhibitors to effectively interact with different parts of the Tpbpa protein, ensuring robust inhibition while maintaining structural stability and functionality in biological conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits gene expression by preventing RNA polymerase activity, potentially suppressing the transcription of trophoblast specific protein alpha gene. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis, potentially leading to reduced expression of trophoblast specific protein alpha by disrupting the elongation phase of translation. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, potentially reducing the production of trophoblast specific protein alpha. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin inhibits bacterial DNA-dependent RNA polymerase, indirectly affecting the expression of trophoblast specific protein alpha in bacterial systems. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin inhibits protein synthesis by blocking peptidyl transferase activity, potentially reducing the expression of trophoblast specific protein alpha. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $255.00 | ||
Actinomycin C inhibits RNA synthesis, potentially downregulating the expression of trophoblast specific protein alpha. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, affecting guanine nucleotide synthesis, which may impact the expression of trophoblast specific protein alpha. | ||||||
Thiolutin | 87-11-6 | sc-200387 sc-200387A | 1 mg 5 mg | $99.00 $398.00 | 1 | |
Thiolutin inhibits RNA polymerase, affecting gene transcription and potentially downregulating the expression of trophoblast specific protein alpha. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, potentially impacting chromatin structure and gene expression, including that of trophoblast specific protein alpha. | ||||||